Regenacy Pharmaceuticals is developing a novel, disease-modifying approach to treating peripheral neuropathies that goes beyond pain and symptom management to restore peripheral nerve function.
Our lead compound ricolinostat (ACY-1215) is an oral, selective inhibitor of the microtubule modifying enzyme HDAC6 with first-in-class potential, currently positioned to enter Phase 2 clinical trials. Our investigation of ricolinostat for diabetic, chemotherapy-induced and inherited peripheral neuropathies is based on compelling proof-of-concept preclinical studies demonstrating restoration of normal nerve function.
We were founded in December 2016 following the acquisition of Acetylon Pharmaceuticals by Celgene. Regenacy received exclusive rights to ricolinostat, a clinical stage, orally bioavailable, HDAC6 selective inhibitor, for a range of non-cancer disease indications. We also have a unique and proprietary portfolio of selective HDAC1,2 inhibitors with potential for treating cancer, hemoglobinopathies, and cognitive dysfunction.
Location: United States, Massachusetts, Waltham
Member count: 1-10
Total raised: $39.3M
Founded date: 2016
Investors 2
Date | Name | Website |
- | 3E Biovent... | 3ebiovc.co... |
- | Cobro Vent... | cobroventu... |
Funding Rounds 2
Date | Series | Amount | Investors | Deal News |
25.08.2022 | Series B | $9.3M | - | vcnewsdail... |
25.03.2020 | Series A | $30M | - | 3ebiovc.co... |
Mentions in press and media 12
Date | Title | Description | Category | Author | Source |
28.09.2022 | Portfolio ... | SHANGHAI, Sept. 28, 2022 /PRNe... | - | - | en.prnasia... |
25.08.2022 | Regenacy P... | WALTHAM, MA, Regenacy Pharma... | - | - | vcnewsdail... |
27.03.2020 | These heal... | Headquarters: Neuchatel, Switz... | - | - | medcitynew... |
26.03.2020 | Regenacy P... | - | - | - | 3ebiovc.co... |
25.03.2020 | Regenacy P... | Regenacy Pharmaceuticals, a Wa... | USA | - | finsmes.co... |
25.03.2020 | Regenacy P... | Treatments for diabetic periph... | Biotech | - | fiercebiot... |
25.03.2020 | Cobro Vent... | WALTHAM, Mass.--(BUSINESS WIRE... | - | - | citybizlis... |
25.03.2020 | Regenacy P... | WALTHAM, Mass.--(BUSINESS WIRE... | - | - | citybizlis... |
25.03.2020 | Regenacy P... | Treatments for diabetic periph... | Biotech | - | fiercebiot... |
25.03.2020 | Regenacy P... | WALTHAM, MA, Regenacy Pharma... | - | - | vcnewsdail... |
Show more